Advocacy intelligence hub — real-time data for patient organizations
Thomas Jefferson University — PHASE2
M.D. Anderson Cancer Center — PHASE2
M.D. Anderson Cancer Center — PHASE1
M.D. Anderson Cancer Center — PHASE1
M.D. Anderson Cancer Center — PHASE2
M.D. Anderson Cancer Center — PHASE2
M.D. Anderson Cancer Center — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Acute myeloid leukemia with t(9;22)(q34.1;q11.2) news →
Brenda Sandmaier
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
📍 SEATTLE, WA
Tapan M Kadia
M D Anderson Cancer Center
📍 Houston, Texas
Elias Jabbour, M.D
M.D. Anderson Cancer Center
📍 HOUSTON, TX
Nitin Jain
M.D. Anderson Cancer Center
Amanda Olson, MD
M.D. Anderson Cancer Center
Samer Srour, MD
M.D. Anderson Cancer Center
📍 HOUSTON, TX
View all Acute myeloid leukemia with t(9;22)(q34.1;q11.2) specialists →